Trial Profile
A Phase 2 Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 22 Mar 2016
Price :
$35
*
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Glioblastoma; Glioma
- Focus Therapeutic Use
- 22 Mar 2016 New trial record